Voloridge Investment Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Voloridge Investment Management’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-29,166	Closed	-$986K	–	1988
2021 Q2	$986K	Buy	+29,166	New	+$743K	0.01%	1258

Voloridge Investment Management's CNST Position: Q3 2021 in Review

Voloridge Investment Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 29,166 shares — an estimated $986K sold.

Voloridge Investment Management first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $986K in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Voloridge Investment Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Voloridge Investment Management sold 29,166 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $986K.
Voloridge Investment Management first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
Voloridge Investment Management's Constellation Pharmaceuticals, Inc. position peaked at $986K in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Voloridge Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.